DE69629559D1 - Peptide und diese enthaltende heilmittel für autoimmunkrankheiten - Google Patents

Peptide und diese enthaltende heilmittel für autoimmunkrankheiten

Info

Publication number
DE69629559D1
DE69629559D1 DE69629559T DE69629559T DE69629559D1 DE 69629559 D1 DE69629559 D1 DE 69629559D1 DE 69629559 T DE69629559 T DE 69629559T DE 69629559 T DE69629559 T DE 69629559T DE 69629559 D1 DE69629559 D1 DE 69629559D1
Authority
DE
Germany
Prior art keywords
amino acid
side chain
independently represents
autoimmune diseases
acid residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629559T
Other languages
English (en)
Other versions
DE69629559T2 (de
Inventor
Nobuyuki Yamagata
Kenji Ogata
Masako Wagatsuma
Hitoshi Takanashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Publication of DE69629559D1 publication Critical patent/DE69629559D1/de
Application granted granted Critical
Publication of DE69629559T2 publication Critical patent/DE69629559T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69629559T 1995-04-07 1996-04-03 Peptide und diese enthaltende heilmittel für autoimmunkrankheiten Expired - Lifetime DE69629559T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP11759295 1995-04-07
JP11759295 1995-04-07
JP7344649A JPH08333390A (ja) 1995-04-07 1995-11-24 ペプチド及びそれからなる自己免疫疾患治療剤
JP34464995 1995-11-24
PCT/JP1996/000917 WO1996031529A1 (fr) 1995-04-07 1996-04-03 Peptides et medicaments contre les maladies auto-immunes contenant ces peptides

Publications (2)

Publication Number Publication Date
DE69629559D1 true DE69629559D1 (de) 2003-09-25
DE69629559T2 DE69629559T2 (de) 2004-06-17

Family

ID=26455689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629559T Expired - Lifetime DE69629559T2 (de) 1995-04-07 1996-04-03 Peptide und diese enthaltende heilmittel für autoimmunkrankheiten

Country Status (13)

Country Link
EP (1) EP0821003B1 (de)
JP (1) JPH08333390A (de)
KR (1) KR19980703610A (de)
CN (1) CN1183784A (de)
AT (1) ATE247664T1 (de)
AU (1) AU704656B2 (de)
CA (1) CA2217679C (de)
DE (1) DE69629559T2 (de)
ES (1) ES2203685T3 (de)
HU (1) HUP9801680A3 (de)
NO (1) NO974566L (de)
NZ (1) NZ304437A (de)
WO (1) WO1996031529A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
IL125262A0 (en) 1998-07-07 1999-03-12 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6935730B2 (en) 2000-04-03 2005-08-30 Unicorn Image Products Co. Ltd. Of Zhuhai One-way valve, valve unit assembly, and ink cartridge using the same
WO2003096966A2 (en) 2002-05-21 2003-11-27 Resistentia Pharmaceuticals Ab Chimeric ige polypeptides and host cells
CN1169829C (zh) 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
JP7000161B2 (ja) 2015-05-26 2022-01-19 ジェムバックス アンド カエル カンパニー，リミティド 新規ペプチド及びこれを含む組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
WO1993006135A1 (en) * 1991-09-23 1993-04-01 Genentech, Inc. Diagnosing and treating autoimmune disorders
EP0666867A4 (de) * 1992-09-14 1997-08-27 Brigham & Womens Hospital Reagentien und methoden zur behandlung rheumatoischer arthritis.

Also Published As

Publication number Publication date
WO1996031529A1 (fr) 1996-10-10
NO974566L (no) 1997-11-26
CA2217679C (en) 2008-03-25
CA2217679A1 (en) 1996-10-10
JPH08333390A (ja) 1996-12-17
KR19980703610A (ko) 1998-12-05
ES2203685T3 (es) 2004-04-16
HUP9801680A3 (en) 1999-06-28
AU704656B2 (en) 1999-04-29
EP0821003A1 (de) 1998-01-28
HUP9801680A2 (hu) 1998-11-30
MX9707662A (es) 1997-11-29
EP0821003B1 (de) 2003-08-20
DE69629559T2 (de) 2004-06-17
EP0821003A4 (de) 2000-05-24
CN1183784A (zh) 1998-06-03
NZ304437A (en) 1999-01-28
ATE247664T1 (de) 2003-09-15
AU5162296A (en) 1996-10-23
NO974566D0 (no) 1997-10-02

Similar Documents

Publication Publication Date Title
EP1718325B1 (de) Behandlung von bakteriellen infektionen
IL112641A (en) Broad spectrum antimicrobial compounds and pharmaceutical compositions containing them
Seebach et al. Chemical and Biological Investigations of β‐Oligoarginines
DE68916932T2 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
EP0629347A1 (de) Antibakterielles mittel und behandlung von gegenständen mit diesem
DE69629559D1 (de) Peptide und diese enthaltende heilmittel für autoimmunkrankheiten
Karlsson Chemistry of some potent animal toxins
Krishnamoorthy et al. Solid-phase total synthesis and structure proof of callipeltin B
CA2453112A1 (en) New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialls
JP4293889B2 (ja) 塩基性抗菌性ペプチドを有効成分とする細胞増殖剤
MY147920A (en) Antibacterial and antiviral peptides from actinomadura namibiensis
JPH06256211A (ja) ウイルス感染・増殖抑制剤
EP0836617A1 (de) Parevine und tachyteprine
US6307016B1 (en) Parevins and tachytegrins
US6982246B1 (en) Cytomodulating peptide for inhibiting lymphocyte activity
TW202221010A (zh) 抑菌擬肽物
RU94004998A (ru) Хризоспермины, способ их получения, лекарственное средство на их основе и штамм apiocrea chrysosperma
JP2000226383A (ja) 新規タンパク質：プレニルトランスフェラ―ゼ阻害剤
US6790829B1 (en) Cyclic decapeptide antibiotics
AU7858794A (en) Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
AU714294C (en) Parevins and tachytegrins
USRE38828E1 (en) Parevins and tachytegrins
Helquist et al. Derivatized virginiamycin M 1
OA10136A (fr) Dérivés de la sorbine procédé pour la synthèse de ces peptides et compositions pharmaceutiques les contenant
ATE132876T1 (de) Hexapeptidderivate von teicoplanin und verfahren zu deren herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition